Intracellular reservoir of Streptococcus pyogenes in vivo: A possible explanation for recurrent pharyngotonsillitis

Laryngoscope

Volumn 107, Issue 5, 1997, Pages 640-647

  Österlund, Anders ^a   Popa, Raul ^a   Nikkilä, Tapio ^b   Scheynius, Annika ^c   Engstrand, Lars ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC TONSILLITIS; CLINICAL ARTICLE; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT INFECTION; RESPIRATORY EPITHELIUM; STREPTOCOCCUS PYOGENES;

EID: 0030950679     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199705000-00016     Document Type: Article

References (45)

1. Markowitz M, Gerber MA, Kaplan EL. Treatment of streptococcal pharyngotonsillitis: reports of penicillin's demise are premature. J Pediatr 1993;123:679-85.
2. Strömberg A, Schwan A, Cars O. Five versus ten days treatment of group A streptococcal pharyngotonsillitis: a randomized controlled clinical trial with phenoxymethylpenicillin and cefadroxil. Scand J Infect Dis 1988;20:37-46.
3. Gerber MA, Randolf MF, DeMeo KK, Kaplan EL. Lack of impact of early antibiotic therapy for streptococcal pharyngitis on recurrence rates. J Pediatr 1990;117:853-8.
4. Green JL, Ray SP, Charney E. Recurrence of streptococcal pharyngitis related to oral penicillin. J Pediatr 1969;75:292-4.
5. Yokoyama Y, Harabuchi Y, Kukuminato Y, Kataura A. Super-oxide production by neutrophils in patients with recurrent tonsillitis [in Japanese]. Nippon Jibiinkoka Gakkai Kaiho 1994;97: 2259-65.
6. Koch RJ, Brodsky L. Effect of specific bacteria on lymphocyte proliferation in diseased and nondiseased tonsils. Laryngoscope 1993;103:1020-6.
7. Koch RJ, Brodsky L. Qualitative and quantitative immunoglobulin production by specific bacteria in chronic tonsillar disease. Laryngoscope 1995;105:42-8.
8. Kundsin RB, Miller JM. Significance of the Staphylococcus aureus carrier state in the treatment of disease due to group A streptococci. N Engl J Med 1964:1395-7.
9. Brook I. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis 1984;6:601-7.
10. Grahn E, Holm SE, Roos K Penicillin tolerance in beta-streptococci isolated from patients with tonsillitis. Scand J Infecit Dis 1987;19:421-6.
11. Kim KS, Kaplan EL. Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. J Pediatr 1985;107:681-4.
12. Sanders CC, Sanders WE, Harrowe DJ. Bacterial interference: effect of oral antibiotics on the normal throat flora and its ability to interfere with group A strepococci. Infect Immun 1976;13:808-12.
13. Crowe C, Sanders E, Longley S. Bacterial interference. II. Role of the normal throat flora in prevention of colonization by group A streptococcus. J Infect Dis 1973;128:527-32.
14. Roos K, Holm SE, Grahn E, Lind L. Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: a randomized placebo-controlled study. Scand J Infect Dis 1993;25:31-5.
15. Roos K, Grahn E, Holm SE, Johansson H, Lind L. Interfering alpha-streptococci as a protection against recurrent streptococcal tonsillitis in children. Int J Pediatr Otorhinolaryngol 1993;25:141-8.
16. Roos K, Grahn E, Ekedahl C, Holm SE. Pharmacokinetics of phenoxymethylpenicillin in tonsils. Scand J Infect Dis 1986;18:125-30.
17. Sheppard MJ, Kelly TW. Phenoxymethyl-penicillin vs coamoxyclav in acute recurrent tonsillitis [letter; comment]. J Antimicrob Chemother 1990;25:474-5.
18. Ågren K, Lundberg C, Nord CE. Effect of amoxycillin/clavulanic acid on the aerobic and anaerobic tonsillar microflora in the treatment of recurrent tonsillitis. Scand J Infect Dis 1990;22:691-7.
19. Stjernquist-Desatnik A, Orrling A, Schalen C, Kamme C. Penicillin tolerance in group A streptococci and treatment failure in streptococcal tonsillitis. Acta Otolaryngol Suppl 1992;492:68-71.
20. Strömberg A, Friberg U, Cars O. Concentrations of phenoxymethylpenicillin and cefadroxil in tonsillar tissue and tonsillar surface fluid. Eur J Clin Microbiol 1987;6:525-9.
21. Tanz RR, Schulman ST, Sroka PA, Maburio S, Brook I, et al. Lack of evidence of beta-lactamase-producing flora on recovery of group A streptococci after treatment of acute pharyngitis. J Pediatr 1990;117:859-863.
22. Foote P Jr, Brook I. Penicillin and clindamycin therapy in recurrent tonsillitis. Effect of microbial flora. Arch Otolaryngol Head Neck Surg 1989;115:856-9.
23. Orrling A, Stjernquist-Desatnik A, Schalen C, Kamme C. Clindamycin in persisting streptococcal pharyngotonsilli-tis after penicillin treatment. Scand J Infect Dis 1994; 26:535-41.
24. Brook I, Leyva F. The treatment of the carrier state of group A beta-hemolytic streptococci with clindamycin. Chemotherapy 1981;27:360-7.
25. Österlund A, Engstrand L. Intracellular penetration and survival of Streptococcus pyogenes in respiratory epithelial cells in vitro. Acta Otolaryngol (Stockh) 1995;115:685-8.
26. LaPenta D, Ruhens C, Chi E, Cleary PP. Group A streptococci invade human respiratory epithelial cells. Proc Natl Acad Sci USA 1994;91:12,115-9.
27. Shikata H. Studies on streptococcus-cell infection system. I. Phagocytosis of streptococcus by various kinds of established cells. Kurume Med J 1963;10:89-99.
28. Stenfors LE, Raisanen S. In vivo attachment of beta-haemolytic streptococci to tonsillar epithelial cells in health and disease. Acta Otolaryngol (Stockh) 1991;111: 562-8.
29. Fornhem C, Peterson CGB, Scheynius A, Alving K. Influence of endogenous cortisol on eosinophil function in sensitized pigs: direct measurements of eosinophil peroxidase. Clin Exp Allergy 1996;26:469-78.
30. Gerber MA, Randolph MF, Chanatry J, Wright LL, De Meo K, et al. Five vs ten days of penicillin V therapy for streptococcal pharyngitis. Am J Dis Child 1987;141:224-7.
31. Schwartz RH, Wientzen R Jr, Pedreira F, Feroli EJ, Mella GW, et al. Penicillin V for group A streptococcal pharyngotonsillitis. A randomized trial of seven vs ten days' therapy. JAMA 1981;246:1790-5.
32. Pichichero ME. Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis: is the difference worth it? Pediatr Infect Dis J 1993;12:268-74.
33. Brook I, Gilmore JD. Evaluation of bacterial interference and β-lactamase production in management of experimental infection with group A beta-hemolytic streptococci. Antimicrob Agents Chemother 1993;37:1452-5.
34. Stevens DL, Gibbons AE, Bergstrom R, Winn V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988;158:23-8.
35. Barza M. Pharmacokinetics of antibiotics in shallow and deep compartments. J Antimicrob Chemother 1993;31:17-27.
36. Tulkens PM. Intracellular distribution and activity of antibiotics. Eur J Clin Microbiol Infect Dis 1991;10:100-6.
37. Pacifico L, Scopetti F, Ranucci A, Pataracchia M, Savignoni F, et al. Comparative efficacy and safety of 3-day azithromycin and 10-day penicillin V treatment of group A beta-hemolytic streptococcal pharyngitis in children. Antimicrob Agents Chemother 1996;40:1005-8.
38. Muller O, Wettich K. Clinical efficacy of dirithromycin in pharyngitis and tonsillitis. JAntimicrob Chemother 1993; 31:97-102.
39. Fassbender M, Lode H, Schiller C, Andro R, Goetschi B, et al. Comparative pharmacokinetics of macrolide antibiotics and concentrations achieved in polymorphonuclear leucocytes and saliva. Clin Microbiol Infect 1996;1:235-43.
40. Kaplan EL, Gastanaduy AS, Huwe BB.The role of the carrier in treatment failures after antibiotic therapy for group A streptococci in the upper respiratory tract. J Lab Clin Med 1981;98:326-35.
41. Tanz RR, Shulman ST, Barthel MJ, Willert C, Yogev R. Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci. J Pediatr 1985;106:876-80.
42. Stjernquist-Desatnik A, Prellner K, Schalen C. High recovery of Haemophilus influenzae and group A streptococci in recurrent tonsillar infection or hypertrophy as compared with normal tonsils. J Laryngol Otol 1991;105:439-41.
43. Forsgren J, Samuelsson A, Åhlin A, Jonasson J, Rynnel-Dagöö B, et al. Haemophilus influenzae resides and multiplies intracellularly in human adenoid tissue as demonstrated by in situ hybridization and bacterial viability assay. Infect Immun 1994;62:673-9.
44. Bieluch VM, Chasin WD, Martin ET, Tally FP. Recurrent tonsillitis: histologic and bacteriologic evaluation. Ann Otol Rhinol Laryngol 1989;98:332-5.
45. Wilson AT. The egestion of phagocytized particles by leucocytes. J Exp Med 1953;98:305-10.